British Peripheral Nerve Society

This meeting is not open to members of the public. BPNS Members should log in to reserve their place, however members in arrears with their subscriptions will not be able to register.

Dinner following Spring meeting 2019

Start Date

End Date

Friday 15 Mar 2019 18:30 PM

Friday 15 Mar 2019 20:30 PM

Location

Bristol

Details

A table for dinner has been reserved at 6:30pm after the scientific meeting at Graze Bar and Chop House. Those wishing to attend should book a place via this event here on the website - we have room for a maximum of 20 people. Booking here will cover a set price menu of 2 courses. A third course and drinks on the night will be at additional cost. Numbers need to be finalised by Sunday 10th March so booking here will close then. You will also need to choose from this menu in advance - please send an email with your choices to Alex McWilliams (secretariat@bpns.org.uk) after reserving a place.

STARTERS

Salt & Pepper Squid - marinated in chilli and garlic, served with aioli and lemon

Crispy Halloumi - with sour cream & chive and sweet chilli dipping

Pork Rilloins - served with apple sauce

MAINS

Rump 226g - with chips and dressed leaves

Flat Iron 226g - with chips and dressed leaves

Graze Cheeseburger - with roas onions, american mustard, ketchup, gherkin and fries

Truffle Mac & Cheese - mozarella, spinach and mushrooms

Gem Ale Battered Fish & Chips - with mushy peas, lemon and tartare sauce

Queen Square Annual Update in Neuromuscular Disorders

This course will be held from Wednesday 13th May to Friday 15th May in the Clinical Neuroscience Lecture Theatre, Lower ground, 33 Queen Square, London WC1N 3B

DETAILS/REGISTRATION

Brain Fellowships

Applications are invited for 1 year fellowships funded by the Guarantors of Brain. These fellowships provide bridging salary support to early career clinicians based in the UK prior to obtaining a research fellowship. Further details can be found HERE

New NHSE commissioning policies for rituximab and IVIg

We are pleased to announce that, largely due to the efforts of our president Prof Lunn, rituximab is now approved for treatment of IgM paraproteinaemic demyelinating peripheral neuropathy (anti-MAG phenotype, with or without anti-MAG antibodies): 1910-rituximab-for-treatment-of-PDPN-policy-v2.pdf (england.nhs.uk). Whilst we have hitherto been able to treat some patients with rituximab by sending them to a haematologist, this was not possible if the bone marrow showed insufficient evidence of underlying lymphoplasmacytic lymphoma. These patients can now be treated, regardless of bone marrow result, either by you or by your friendly haematologist, under the new commissioning guidance.
Also thanks to Prof Lunn (alongside non-neurology colleagues), the updated IVIg commissioning policy is now available: Commissioning-Criteria-Policy-for-the-use-of-Ig-Version-Finala.pdf (mdsas.com). Newly commissioned diagnoses of relevance to peripheral nerve now include acute autoimmune autonomic ganglionopathy, and neuromyotonia.
Finally, with thanks largely to the efforts of Dr Rinaldi in Oxford, rituximab can now be used for the treatment of autoimmune nodopathies (with nodal/paranodal antibodies): NHS England » Rituximab therapy for the treatment of nodal/paranodal antibody positive inflammatory/autoimmune neuropathy in adults and postpubescent children.

GWAS study of CIDP

Members are encouraged to participate in a genome-wide association study of CIDP. Brief details can be found HERE

More news »

Meetings

Queen Square Annual Update in Neuromuscular Disorders

Brain Fellowships

New NHSE commissioning policies for rituximab and IVIg

GWAS study of CIDP